Background-Ionizing radiation (IR) initiates intracellular oxidative stress through enhanced formation of reactive oxygen species (ROS) that attack DNA leading to cell death. As the diversity of IR applied in medicine, agriculture, industry, and the growing threats of global terrorism, the acquisition of radioprotectors is an urgent need for the nation. However, the applicability of radioprotectors currently under investigation is limited due to their inherent toxicity.
Introduction
It is well known that exposure of normal tissue cells to ionizing radiation (IR) activates genetic cascades of signaling events, generating free radicals collectively known as reactive oxygen species (ROS), which attack DNA, ultimately leading to cell death. Due to the increased utilization of IR in human life and the growing threats of global terrorism, IR-induced normal tissue morbidities are of further importance to both civilians and military populations, since they are potentially subject to accidental or intentional nuclear mishaps. Hence, the development of efficacious radioprotector would be a contribution to radiation oncology, public health, national defense, and environmental remediation. [1] [2] [3] The term "radioprotector" primarily refers to free radical scavengers that avert the initial radiochemical events in cells following IR exposure. Currently, the majority of potential radioprotective chemical compounds under investigation are designed to scavenge IR-induced free radicals. Nevertheless, their efficacy is linked to high-drug dosages that will evoke unacceptable side effects, and none of these agents is available for human use outside the clinic. 2 Thus, the search for less-or nontoxic agents to counter the effects of IR remains an area of intense focus. 1, 2 Natural products such as herbal medicines with an abundance of antioxidant resources have received attention as possible radiation modifiers. 4 Herbal medicine, or phytomedicine, is generally considered a well-established form of complementary medicine. Ginseng is one of the most frequently purchased herbs in the US marketplace and is frequently taken orally as a traditional herbal medicine. 5 The term ginseng refers to the dried root of several species in the plant genus Panax, which belongs to the Araliaceae family; it comprises two commonly used ginseng species, i.e., Panax ginseng C.A. Meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng). These two forms of ginseng have drawn worldwide attention for their broad medicinal potential, such as antiaging, antidiabetic, anticarcinogenic, antihypertension, antipyretic, antistress, analgesic, and antifatigue effects, as well as their enhancement of immune response to polyclonal stimulation and promotion of DNA, RNA, and protein synthesis. [5] [6] [7] [8] [9] Recently, in a 18.8 years cohort study based on 6282 human subjects, Yi et al found that ginseng intake significantly decreased all-cause martality in older Korean males. 5 The predominant bioactive components of ginseng are a diverse group of triterpenoid saponins with steroidal structures, labeled ginsenosides. Although the mechanisms are still largely unknown, the medicinal properties of ginseng have been closely related to the effects of ginsenosides against free radical attack. 6 -8,10 After the exposure of mammalian cells to ionizing radiation (IR), an unregulated production of ROS, associated with a shift in the intracellular oxidant-antioxidant balance towards a prooxidant state, triggers damage to cellular membranes and DNA, leading to a state of oxidative stress. However, because effective antioxidants are free radical scavengers that interfere with radical chain reactions, it is possible to protect cellular DNA from oxidative stress by supplementation with antioxidants. [11] [12] [13] [14] Studies of the radioprotective effect of ginseng have been performed primarily with the application of Asian ginseng in rodent models. 8 ,15 Micronuclei (MN) in interphase mammalian cells are reliable biomarkers for evaluating IR-induced chromosome damage. 16 , 17 We recently found that incubation with Asian ginseng dried root crude water extract (100 µg-2000 µg ml −1 ) 24 h before 137 Cs exposure significantly reduced radiation-induced (MN) yield in peripheral blood lymphocytes (PBL) obtained from four human subjects.18 However, although North American ginseng (NAG) is one of the best-selling herbs on the market, relative few studies have involved NAG.8 The purpose of this study was to investigate whether radioprotective effect of a standardized North American ginseng extract (NAGE) could also be achieved in human PBL when applied postradiation. The hypotheses behind this study are (1) that IR-induced oxidative injury in PBL is preventable by the administration of exogenous antioxidants; and (2) that the radioprotective effect of NAGE on human PBL is a result of modulation of the activity of the intracellular antioxidant defense systems. To test these hypotheses, we investigated the impact of NAGE when applied 90 min after 137 Cs exposure on MN yield in PBL obtained from 40 healthy individuals. The MN results in PBL obtained from NAGE application were compared with similar experiments using WR-1065, the biologically active aminothiol form of amifostine (WR-2721), which is currently the only "gold standard " of radioprotectors approved by the US Food and Drug Administration. 19 , 20 In addition, in ten of these individuals, we also evaluated the correlation between the effect of NAGE on intracellular total antioxidant capacity (TAC), levels of ROS production, and MN yield in PBL before and after 137 Cs exposure. Although preliminary, we believe that the information generated from these in vitro studies will provide the foundation for in vivo trials to assess the potential of NAGE as a natural dietary radiation countermeasure.
Materials and Methods

Subjects
Our University Medical Center Institutional Review Board approved this study. A total of 40 healthy individuals (23M/17F) 43.3 ± 2.2 (mean ± SEM) years of age, without known history of exposure to mutagens, were recruited in this study. No individuals were currently taking any other pharmacologic agents, including medications, vitamins, or dietary supplements. All participants signed informed consent before enrollment.
NAGE preparation and ginsenosides content
The standardized NAGE powder (Lot-TKGS-010406) was purchased from Canadian Phytopharmaceuticals Corporation (Richmond, BC, Canada). Using high-performance liquid chromatography, the major ginsenosides in this NAGE powder were characterized by the vendor as follows: Rb1 (5.1%), Rb2 (0.99%), Rc (1.88%), Rd (1.23%), Re (2.14%), and Rg1 (0.36%) with total ginsenoside content (w/w) of 11.7%. To ensure stability, the NAGE was stored in a cool, dry, dark location over the course of the study. Before experimentation, 50 mg of the lyophilized NAGE powder was dissolved in 5 ml 1× RPMI culture medium (SigmaAldrich, MO, USA), filtered through a 0.2 µm disc (Millipore, MA) under sterile conditions, and was used as the stock solution.
Cytokinesis-block (CB) MN assay
Fresh peripheral blood samples were drawn from each individual into Vacutainer Cell Preparation Tubes (Becton-Dickson, NJ, USA). Mononuclear cells were isolated by density gradient centrifugation at 1800 g for 20 min, washed, and counted on a hemacytometer. Trypan blue exclusion showed the viability to be greater than 95%. The purity of mononuclear cells was >95% as determined by Hema-3 staining (Fisher Scientific, NC, USA). For each culture, 2-3 × 10 5 cells ml −1 were incubated in polystyrene culture tubes containing 1× RPMI 1640 culture medium (Sigma Chemical, MO, USA), supplemented with 10% fetal calf serum, Lglutamine (0.03%), and penicillin (100 IU ml −1 ) and streptomycin (100 µg ml −1 ). The final volume of each culture was 1 ml. Duplicate cultures were set up for each experimental point within 60 min after venipuncture. Phytohemaglutinin (PHA, M Form, Invitrogen Corp. CA, USA) was added to each culture (15 µl ml −1 ) immediately after ex vivo radiation exposure.
Cytochalasin B (Sigma Chemical, MO, USA) was applied at 44 h after the PHA stimulation, with a final concentration of 4 µg ml −1 . All cultures were maintained in a humidified atmosphere of 5% CO 2 at 37°C following another 24 h and cells were collected by centrifugation at 300 g for 10 min. The slides, prepared according to the method of Fenech et al, 16 , 17 were stained with Hema-3 (Fisher Scientific, NC, USA).
Application of NAGE
To ascertain the optimum radioprotective dose of NAGE, a series of preliminary studies were carried out (Data not shown). Treatment of PBL with NAGE at 500 -750 µml −1 at 0 h was found to cause a significant reduction in 137 Cs-induced MN yield. Therefore, for the determination of a dose-response radioprotective effect of NAGE, in each experiment, four different concentrations (250, 500, 750, and 1000 µg ml −1 ) of NAGE were applied to mononuclear cell cultures (2 × 10 5 cells ml −1 ) in RPMI 1640 90 min after exposure to 137 Csirradiation for CBMN assay.
WR-1065 preparation and application
WR-1065 was kindly provided by Dr. Robert J. Schultz (Drug Synthesis and Chemistry Branch, NIH-NCI, Bethesda, MD, USA). A stock solution (10 mM) of WR-1065 was made up with RPMI 1640 culture medium and was kept frozen. The stock solution was thawed on ice immediately before use and was filtered through a 0.2 µm disc (Millipore, MA), the remainder was quickly frozen again after use.
For each experimental condition, we serially diluted the stock solution of WR-1065 with the culture medium to the final concentrations (1 mM or 3 mM). We then applied WR-1065 (1 mM or 3 mM) to mononuclear cell cultures (6 × 10 5 cells ml −1 ) at 90 min post irradiation. After the 10 min treatment with WR-1065, the cell cultures were centrifuged, washed with phosphate-buffered saline (PBS) to remove the WR-1065, and were resuspended in the RPMI 1640 culture medium for the completion of the CBMN assay.
Ex vivo irradiation
The human G 0 PBL were exposed ex vivo to 137 Cs γ-rays (Gamma Cell 40, Radiation Machinery, Ontario, Canada) with 1 or 2 Gy (0.6 Gy/min) at room temperature (22° C), and NAGE was applied to the culture medium 90 min after irradiation.
Microscopy
Slides were coded and randomized to ensure anonymity upon scoring. For consistency, the microscopy was performed by one researcher (WW). Under 400× magnification, in continuous fields from two slides prepared for each experimental checkpoint, he scored a minimum of 1000 binucleated (BN) cells where possible. The quantification of MN yield was restricted to BN cells with distinct intact cytoplasm and included those with nuclear bridges. MN with smooth edges touching the main nucleus and those with clearly defined overlap were also included in the count. The distribution of MN number in each BN cell was also recorded. The MN yield was determined as MN yield = (Total number of MN in BN cells/Total number of scored BN cells) × 1000. Percentage reduction of MN was determined as 137 Cs-induced MN yield in varying concentrations of NAGE compared to that with radiation alone.
Measurement of the intracellular total antioxidant capacity (TAC) in PBL
In addition to their CBMN assay, blood samples obtained from 10 (6M/4F, 42.7 ± 4.6 years of age) of the 40 individuals were studied to determine the intracellular TAC level in PBL. Using the Antioxidant Assay Kit (Sigma, CS-0790), PBL (1 × 10 6 cells ml −1 ) before and at 90 min post irradiation, were incubated with different concentrations of NAGE for 24 h for the determination of intracellular TAC. The antioxidant assay is based on the formation of a ferryl myoglobin radical from myoglobin and hydrogen peroxide, which oxidizes ABTS [2,2'-azinobis-(3-ethyl-benzothialozine-6-sulfonic acid)] to produce a radical cation ABTS + , a soluble green chromogen that can be determined at 405 nm. In the presence of antioxidants, the radical cation is suppressed to an extent dependent on antioxidant activity, and the color intensity is decreased proportionally. Trolox, a water-soluble vitamin E analogue, served as a control antioxidant. In brief, at the end of the 24 h incubation, PBL were sonicated on ice in 1 ml of cold 1× assay buffer and centrifuged at 12000 g for 15 min (4°C). In a 96-well culture plate, the supernatant of PBL lysates (10 µl) in each well was mixed with 1× myoglobin working solution (20 µl), ABTS substrate working solution (150 µl), and 3% hydrogen peroxide (25 µl) and allowed to incubate at 25°C for 30 min. For the Trolox standard curve, 10 µl of a Trolox standard and 20 µl of myoglobin working solution were added to each well. Kit stop solution (100 µl) was then added to each well. Samples were read immediately at 406 nm excitation/530 nm emission on a plate reader. Results were calculated using a reference curve based on Trolox as a standard, and intracellular TAC in PBL was expressed in mM Equivalent/L.
Measurement of intracellular oxidative stress in PBL
In addition to their CBMN assay, blood samples obtained from 10 (6M/4F, 42.7 ± 4.6 years of age) of the 40 individuals were studied to determine the intracellular ROS level in PBL. In brief, using the Live Cell Fluorescent Reactive Oxygen Species Detection Kit (MGT-M1049, Marker Gene Technologies, Eugene, OR), before and at 90 min post 137 Cs exposure, PBL (1 × 10 6 cells ml −1 ) were incubated with different concentrations of NAGE for 24 h. At the end of the incubation, the culture medium was aspirated after centrifugation (1000 g, 15 min) and pellets were suspended in ROS inducer, i.e. t-butyl hydroperoxide (TBHP) working solution (100 µM), then incubated for 60 min at 37°C. After centrifugation, PBL pellets were resuspended and incubated in darkness for 45 min in 2',7"-dichlorofluorescein diacetate (25 µM), which is a cell-permeable substrate and a reliable fluorogenic marker for ROS detection. Upon enzyme activity, the highly fluorescent dye, 2',7"-dichlorofluorescein was produced. The cellular fluorescence from each well was determined using 480 nm excitation/535 nm emission with a microplate spectrofluorometer. The values of fluorescence intensity, reflecting the intracellular concentration of ROS in PBL, were expressed as percentage of controls.
Statistical analyses
All measurements were represented as the mean and standard error of the mean (± SEM) and were blinded as to subject status. We used the software package SPSS for the data analysis. 21 Statistical methods consisted of repeated measures of ANOVA and linear regression using a mixed-model approach with random intercepts. Linear contrasts were used to examine the effect of NAGE (0 -1000 µg ml −1 ) on radiation-induced MN yield in PBL and were completely cross-classified in a factorial fashion. The effect of radiation on MN yield of PBL in the presence and absence of NAGE, and the interactions between radiation doses and concentrations of NAGE were evaluated separately. Associations between MN yield and intracellular TAC and ROS levels in PBL were assessed by Pearson's correlation test. 137 Cs exposure (Table 1) Before irradiation and in the absence of both NAGE and WR-1065, mean (± SEM) baseline MN yield of PBL obtained from the 40 healthy individuals was 16.7 ± 0.9 per 1000 BN cells. The presence of NAGE (250 -1000 µg ml −1 ) or WR-1065 (1mM or 3 mM) in PBL culture medium did not affect the MN yield significantly.
Results
Effect of NAGE and WR-1065 on MN yield in PBL before
Effect of NAGE and WR-1065 applied at 90 min after 137 Cs exposure on MN yield in PBL
Radiation alone (1 Gy and 2 Gy) sharply increased the MN yield in PBL in a dose-dependent manner (Table 2 , P<0.001). However, both NAGE (250 -1000 µg ml −1 ) and WR-1065 (1mM or 3 mM) significantly reduced the MN yields as their concentration increased ( Table  1) . The best-fitting line for this relationship was Y = C + αD + βD 2 (Table 2, P<0.001), where Y is the MN per 1000 BN cells and C is the intercept, D is the concentration of NAGE or WR-1065, and α and β are the linear and quadratic coefficients, respectively. Table 1 shows that, when compared with radiation alone, application of NAGE (750 µg ml −1 ) reduced MN yield by 50.7% after 1 Gy and 35.9% after 2 Gy exposure, respectively; the application of WR-1065 (3 mM) reduced MN yield by 52.0% after 1 Gy and 33.4% after 2 Gy exposure, respectively. Fig 1B illustrates the variations of intracellular TAC levels in PBL obtained from 10 health individuals. Before 137 Cs irradiation and in the absence of NAGE in the PBL culture medium, the baseline TAC level in PBL was 1.0 ± 0.1. However, it increased in PBL before irradiation with increments in NAGE concentration (250-1000 µg ml −1 ) in a concentration-dependent manner (P<0.001). In contrast, IR exposure of PBL results in a decline in the intracellular TAC level in PBL. After 137 Cs exposure (1 Gy and 2 Gy) of PBL, baseline TAC levels in PBL decreased with increasing radiation dose (P<0.001). When NAGE was applied to the culture medium 90 min after radiation exposure, as compared with radiation alone (1 Gy and 2 Gy), TAC levels in irradiated PBL increased significantly (P<0.01).
Effect of NAGE applied before and 90 min after 137 Cs irradiation on intracellular TAC status (mM Trolox equivalent/L) in PBL
Effect of NAGE on intracellular ROS status (% of Control) in PBL before and 90 min after 137 Cs irradiation (Fig. 1C)
Before irradiation and in the absence of NAGE in the PBL culture medium, baseline fluorescent ROS level in PBL obtained from 10 healthy individuals was 11.1 ± 2.2. IR exposure of PBL results in an increase in the intracellular ROS level in PBL. The ROS level in irradiated PBL increased significantly with radiation dose to 62.5 ± 6.6 after 1 Gy and 85.3 ± 6.6 after 2 Gy exposure. However, when NAGE was applied to culture medium 90 min post exposure, the intracellular ROS level in irradiated PBL decreased significantly with the NAGE concentration (P<0.001).
Discussion
In this ex vivo study of peripheral blood lymphocytes (PBL) obtained from 40 healthy human subjects, we have demonstrated the potential of a standardized North American ginseng extract (NAGE) and WR-1065 to modulate 137 Cs-induced oxidative stress in PBL at 90 min after exposure, thereby indicating their post-exposure radioprotective effect. The cell membrane of PBL has very high phospholipid content, rendering PBL vulnerable to oxidative damage. 7 Micronuclei (MN) formation in PBL is a well-established biomarker for radiation-induced damage and free radical impacts. 22 We irradiated PBL with 1 -2 Gy, because this dose range induces significant DNA damage, without the possibility of instant killing or causing selective interphase cell death.
The radioprotective effect and the antioxidative potentials of ginseng are no longer novel findings; 15, 18, 23, 24 nevertheless, to the best of our knowledge, no published data has ever been used to analyze the effect of NAGE on intracellular oxidant-antioxidant homeostasis in human PBL after irradiation. We made three interesting findings in this study. First, at 90 min post irradiation, both NAGE and WR-1065 significantly reduced the 137 Cs-induced MN yields in a concentration-dependent manner (Table 1 and Table 2 ). This relatively long postirradiation protective window of the two agents could be of potential clinical interest if it is upheld in in vivo studies.
Second, we also found that at 90 min post irradiation, the maximum reduction rates by NAGE (750 ug ml −1 ) and WR (3 mM) of MN yields in PBL were 50.7% and 52% after 1 Gy and 35.9% and 33.4% after 2 Gy irradiation, respectively (Table 1) . These results suggest the potential of NAGE against radiation-induced MN production in PBL is comparable to that of WR-1065. In addition, at concentrations up to 1000 µg ml −1 (NAGE) or 3 mM (WR-1065), respectively, no modulation of MN yield was found in PBL before irradiation ( Table 1 ), indicated that this protection is accomplished without apparent genomic toxicity in PBL.
Third, we further observed in PBL obtained from 10 human subjects that the rise in 137 Csinduced MN yields in PBL is paralleled by the ROS level at the time of irradiation in a radiation dose-dependent manner (P=0.03-0.005) , but is inversely correlated with the reduction of TAC (P=0.005 -0.001) (Fig. 1A-C) . This finding suggests that the existing endogenous antioxidants in PBL were not able to counteract the 137 Cs-induced oxidative stress, and thus the increased MN production was a function of ROS accumulation and DNA damage. However, with the application of NAGE to the culture medium (250 -1000 µg ml −1 ) at 90 min post irradiation, the observed significant increase in intracellular TAC level and concomitant decrease of both MN yield and ROS level strongly indicate a restoration of antioxidant capacity in PBL by NAGE treatment.
The exact mechanism underlying the post-exposure radioprotective effect of NAGE is unclear. Like WR-1065 in part by the upregulation of the manganese superoxide dismutase (SOD2) gene, 19, 25 , 26 ginseng confers radioprotection by scavenging IR-induced ROS. Since the molecular components of ginseng responsible for this scavenging action are ginsenosides7 ,8 , the radioprotective potential of ginseng is likely directly related to its ginsenoside content, which is quite high in our NAGE formulation (11.7%). Ginsenosides in NAGE are capable of intercalating in the plasma membrane, leading to changes in membrane fluidity and eliciting a cellular response to IR-induced cytotoxic stress. 27 We found in this study that the application of NAGE to the culture medium at 90 min post 137 Cs exposure, significantly increased intracellular TAC levels and was accompanied by a significant decrease in both ROS and MN yields in PBL (Fig.1) . Under our experimental design, the intracellular TAC in PBL represents the cumulative antioxidant capacity, including both NAGE-derived antioxidants and those of endogenous origin. Our findings suggest that (1) the lipid-soluble and water-soluble antioxidant of NAGE permeate into PBL and suppress 137 Cs-induced MN and ROS via OH radical scavenging; (2) this action could be occurring directly through free radical scavenging or indirectly through upregulation of antioxidant enzymes. 10, 28 Based on our findings concerning antioxidant activity at cellular level, it appears that the post-exposure protection of NAGE may be due either to its potential for modulating the redox homeostasis or for boosting the intracellular antioxidant defense system in human PBL.
Our findings are in agreement with the belief that supplementation of antioxidants could inhibit the ROS-induced DNA damage in human PBL. 13 However, our results were generated from ex vivo experiments after up to 2 Gy irradiation of PBL. Also, the antioxidant capacities of NAGE measured ex vivo may not be consistent with their effects in vivo. For instance, after oral ingestion of ginseng, both gastric digestion and hydrolysis by intestinal microflora lead to the biotransformation of ginsenosides 29 . Subsequently, ginsenoside metabolites can be absorbed into the blood, whence they can exert their active pharmacological effects. Since intestinal bacteria are sensitive to host conditions, the individual physiological variations in bacteria-hydrolyzing potentials may affect the radioprotective efficiency of NAGE. Thus, the clinical relevance of our findings that the concentration of NAGE at 750 µg ml −1 reduced both MN yields and ROS levels in human PBL ex vivo (Table 1, Fig. 1 ) would be hard to predict. We are planning to answer these questions in a future research project.
Currently, amifostine (WR-2721) is the only radioprotective agent approved by the FDA for cancer patients undergoing radiotherapy. However, the limitations associated with amifostine include its inherent toxicity, high cost, intravenous administration route to be applied 15 min before radiotherapy, and possible tumor protection. 1, 2 , 30 In contrast, NAGE is a relatively non-toxic, inexpensive natural product with broad medicinal and pharmacological activities, including antitumor activity that can be orally administered under emergency conditions or as a dietary supplement. We believe, therefore, that NAGE is a candidate eminently suited for addition to the list of potential radioprotectors.
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